Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT02440620
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of HER2 positive breast cancer
* Adjuvant treatment with trastuzumab
Exclusion Criteria:
* Left ventricle ejection fraction (LVEF) \<50%
* Chronic or persistent atrial fibrillation
* History of moderate or severe valvular heart disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02440620
Study Brief:
Protocol Section:
NCT02440620